A) upper panel (dataset GSE172114), comparison of S100A12 and IFI27 expression in moderate and critical COVID-19 patients. B) lower panel (dataset Zenodo 6120249), comparison of S100A12 and IFI27 expression in COVID-19 patients with different severity (non-hospitalized, moderate, severe and critical).</p
Abstract With many countries strapped for medical resources due to the COVID-19 pandemic, it is high...
Immune and inflammatory responses to SARS-CoV-2 contribute to disease severity of COVID-19. However,...
ObjectivesOur objective was to determine the antibody and cytokine profiles in different COVID-19 pa...
A) upper panel (dataset GSE161731), comparison of S100A12 and IFI27 expression in healthy controls a...
A) upper panel (dataset GSE152641), comparison of S100A12 and IFI27 expression in healthy controls a...
A) upper panel (dataset GSE184401), comparison of S100A12 and IFI27 expression in COVID-19 patients ...
A) upper panel, comparison of S100A12 and IFI27 expression in healthy controls and COVID-19 patients...
A) upper panel (dataset GSE189990), comparison of S100A12 expression in COVID-19 patients with diffe...
A) upper left (dataset GSE68310), tracking of IFI27 expression in a community cohort with seasonal i...
For coronavirus disease 2019 (COVID-19), a pandemic disease characterized by strong immune dysregula...
A) upper left (dataset Zenodo 6120249), correlation between IFI27 expression and time since symptom ...
Robust biomarkers that predict disease outcomes amongst COVID-19 patients are necessary for both pat...
BACKGROUND: The correlates of COVID-19 illness severity following infection with SARS-Coronavirus 2 ...
Immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes mild symptoms in the majorit...
Abstract With many countries strapped for medical resources due to the COVID-19 pandemic, it is high...
Immune and inflammatory responses to SARS-CoV-2 contribute to disease severity of COVID-19. However,...
ObjectivesOur objective was to determine the antibody and cytokine profiles in different COVID-19 pa...
A) upper panel (dataset GSE161731), comparison of S100A12 and IFI27 expression in healthy controls a...
A) upper panel (dataset GSE152641), comparison of S100A12 and IFI27 expression in healthy controls a...
A) upper panel (dataset GSE184401), comparison of S100A12 and IFI27 expression in COVID-19 patients ...
A) upper panel, comparison of S100A12 and IFI27 expression in healthy controls and COVID-19 patients...
A) upper panel (dataset GSE189990), comparison of S100A12 expression in COVID-19 patients with diffe...
A) upper left (dataset GSE68310), tracking of IFI27 expression in a community cohort with seasonal i...
For coronavirus disease 2019 (COVID-19), a pandemic disease characterized by strong immune dysregula...
A) upper left (dataset Zenodo 6120249), correlation between IFI27 expression and time since symptom ...
Robust biomarkers that predict disease outcomes amongst COVID-19 patients are necessary for both pat...
BACKGROUND: The correlates of COVID-19 illness severity following infection with SARS-Coronavirus 2 ...
Immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes mild symptoms in the majorit...
Abstract With many countries strapped for medical resources due to the COVID-19 pandemic, it is high...
Immune and inflammatory responses to SARS-CoV-2 contribute to disease severity of COVID-19. However,...
ObjectivesOur objective was to determine the antibody and cytokine profiles in different COVID-19 pa...